Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Clinical trial NCT02415959 · COMPLETED

Trial details

NCT number: NCT02415959
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis

Start date: 2015-03-01
Primary completion: 2015-07-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.